LVOT study was to identify the genetic etiology of LVOT congenital CVMs (including aortic valve stenosis, coarctation of the aorta, bicuspid aortic valve, hypoplastic left-heart syndrome, mitral valve stenosis, mitral valve atresia, Shone complex, and interrupted aortic arch type A). Eligible probands (index cases with an LVOT malformation) were identified from the cardiology clinic and/or inpatient records at Nationwide Children's Hospital. Participation in the LVOT study included the collection of medical and pregnancy history of the mother and family, a detailed pedigree (at least three generations), and permission to access the medical record prospectively. Permission was obtained to request medical records from outside the institution via a signed medical release. A blood, tissue, or saliva sample was obtained from the identified proband and, if possible, the parents and any additional relatives with a CVM. Individuals consented to storage of their biologic sample indefinitely for use in a variety of genetic analyses, including genotyping for association studies and sequencing, and for establishment of an immortalized cell line. Subjects could also opt in to allow anonymous sharing of their biologic sample with other investigators. In addition to standard HIPAA (Health Insurance Portability and Accountability Act) language, subjects were informed of the National Institutes of Health (NIH) policy for sharing of data obtained in NIH-supported or -conducted genome-wide association studies, which requires NIH funded investigators to share genotyping and sequencing results in the dbGAP database after deidentifying their data. The consent document stated that the investigators of the LVOT study also obtained a certificate of confidentiality from the NIH to further protect subjects.
inclusion/exclusion criteria
This study included parents of probands who consented to participate in the LVOT study during the period 1 April 2004 through 1 April, 2008 . Probands up to 20 years of age at the time of consent for the LVOT study, whose parents were also included in the consent process, were eligible. Families were deemed ineligible if there was no record of parent consent, the parent involved in the LVOT consent process was unavailable due to changes in custody, valid contact information could not be obtained, or the proband was deceased.
Eligible families were sent a letter introducing the study and were given the opportunity to decline participation by e-mail or phone. Survey packets were then mailed to all eligible families who did not decline to participate, and each parent or guardian in the household was asked to complete the surveys. Instructions were provided indicating respondents were not to assist each other with answering the questions. A $3 cash incentive was included in the survey packet for participation in the study. If no response was received within 2 weeks, families were sent a second packet. If there was no response following the second mailing, families were given a follow-up call.
Measuring informed consent understanding
Understanding of informed consent was measured using the Quality of Informed Consent (QuIC) assessment, which has been validated in parents of pediatric cancer patients and biobank participants. [12] [13] [14] This brief measure assesses understanding of the following domains: (i) the purpose of the research; (ii) the expected duration of participation; (iii) the procedures; (iv) the experimental procedures; (v) the foreseeable risks or discomforts; (vi) the benefits that may be reasonably expected; (vii) the appropriate alternative procedures or treatments; (viii) the confidentiality of research records/participant information; (ix) the compensation and the medical treatment provided if injury results; (x) whom to contact if the participant has questions about the study, participants' rights, or a research-related injury; and (xii) the voluntary nature of research, including the right to refuse participation or withdraw without any penalty or loss of benefits.
The QuIC assessment includes measures of both objective (how well individuals understand their clinical trial/study; part A) and subjective (how well informed participants believe themselves to be; part B) understanding. To reflect the unique procedures and risks in the LVOT study, the QuIC scales were modified to address the storage and future use of biospecimens for other research studies, the possible psychological risks associated with participating in the biobank, and the disclosure of results performed on the stored samples, both now and in the future (Tables 1 and 2 ). These questions were formulated with the genetic counselor (S.M.F.) and the principal investigator (K.L.M.) of the LVOT study.
Participants' responses to the questions on the QuIC assessment were assigned numerical scores. A total QuIC objective score was constructed by calculating the proportion of correct responses. Responses marked as unsure were treated as incorrect when calculating the total score.
The QuIC subjective subscale required respondents to indicate how well informed they believed themselves to be on a rating scale from 1 to 5, where a rating of 1 indicates little to no understanding and a rating of 5 indicates very good understanding for each of 14 aspects of the study. The scores of these 14 items were averaged, resulting in a summary raw score that ranged from 1 to 5.
Statistical analysis
The PROC GENMOD procedure in SAS 9.2 (SAS Institute, Cary, NC) was used to analyze all outcomes because it accounts for correlation by family to accurately derive estimates of effect when comparing QuIC scores across groups. Clustered data were analyzed by using the REPEATED statement in PROC GENMOD, which calls upon generalized estimating equations to model the outcomes of interest.
All knowledge scores from the QuIC objective subscale were compared on characteristics of interest by specifying a binary distribution in PROC GENMOD, resulting in Wald statistics with associated P values. Results of the final model are presented as coefficient estimates, z-scores, and P values, as well as the overall model χ 2 score statistic for significant associations. To account for the multiple tests performed in this study, statistical significance was set at P < 0.01. The QuIC subjective subscale was examined using mean scores for individual items. The mean scores were compared among all independent variables using PROC GENMOD as previously described.
rESuLtS
A total of 392 families were considered for inclusion in the study. Two families were excluded because the consenting parents no longer had custody of the probands, one family was excluded because the proband was deceased, and 11 families were excluded because a current, valid address could not be obtained. Of the 378 eligible families, 2 declined participation and 188 completed the surveys, yielding a response rate of 50%. These 188 families represented a total of 287 individuals, of which 252 (88%) completed the QuIC questionnaires. The remaining individuals stated that they were not present during the informed consent process for the LVOT study; therefore, they were not eligible to complete the questionnaires.
The characteristics of parents who participated in this study are presented in Table 3 . The majority of participants were female (67%), white (94%), college educated (73%), and mothers of the proband (63%). Nearly 70% were employed or selfemployed, and 13% were employed in the health or science field. Approximately 20% of the parents indicated that they or their child had participated in a prior research study. The average age of probands at the time of consent for the LVOT study was 7.5 ± 6.0 years. The mean number of years since enrollment in the LVOT study was 3.1 ± 1.4 years. In most cases (52%), the mother was the primary medical caretaker of the proband and both parents were usually involved in medical decision making (76%). Comparison of demographics and proband characteristics between respondents and nonrespondents did not show any statistical differences.
The proportion of parent responses for each question and the mean score for each item of the QuIC assessment is presented in Table 1 . More than 90% of participants correctly answered statements on consent for research participation (A1), use of family medical history (A11), no direct benefit (A14), purpose of research to understand cause of CVMs (A16), and ability to refuse participation (A24). Conversely, <40% of participants correctly answered statements about use of leftover samples (A4), main study purpose is to find out how to treat my child (A6), indefinite storage of samples (A12), risks and harms (A13), receipt of research results (A17), and payment of care due to injury from research (A21). The consent form language corresponding to the items with lower understanding can be found in Supplementary Table S1 online.
Multivariate analyses revealed some associations between parent or proband characteristics and individual QuIC part A items ( Table 4) . Parents aged ≤40 years were less likely to respond correctly to items A4 (use of leftover samples) and A20 (who to contact with questions) than parents aged 40 years and older. Male participants were less likely to respond correctly to A22 (ability to withdraw participation) as compared with female participants. Marital status was significantly associated with correctly answering items A6 (main study purpose is to find out how to treat my child) and A8 (diagnosing CVMs in family members), with married parents more likely to respond correctly to each question. Medical decision making by both the parents was associated with correctly answering items related to the return of research results (items A4 and A17). Original research article
Conversely, medical decision making by both the parents was inversely associated with correct responses for items describing the indefinite storage of samples (items A9 and A12). As compared with those who had participated in research studies other than the LVOT study, individuals who had not participated in other studies and those who were not sure whether they had participated in other studies were less likely to respond correctly to A18 (anonymous data sharing with the NIH). Parents with higher incomes were less likely to respond correctly to item A21 (payment of care due to injury from research) as compared with participants with incomes <$35,000. As compared with participants who consented for the LVOT study 4 or more years ago, participants who consented <2 years ago were more likely to respond correctly to A21. The results for the QuIC subjective subscale are presented in Table 2 . Overall, participants felt that they understood that they were participating in research (4.6), that the study involved genetic research (4.4), and that participation in the study was voluntary (4.6). Participants seemed less certain about the risks of study participation (3.9) , that their samples would be stored indefinitely (3.3) , and that they could decline for their samples to be used in other studies (3.3) .
The proportion of individuals who answered questions correctly in QuIC part A items was compared with how well the individual thought they understood the item in QuIC part B. Low concordance (proportion answering incorrectly who thought they understood the question) was noted for A13/B7 (risks and harms; 7%), A4/B5 (use of leftover samples; 34%), A21/B11 (payment of care due to injury from research; 35%), and A12/B6 (indefinite storage of samples; 38%).
diScuSSion
In this study of informed consent understanding, we found that parents often overestimated the personal benefit their child and/or family would receive from participation in a genetic study and undervalued the risks associated with study participation. This supports previous studies of informed consent understanding for adults consenting to participate in research studies. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] However, our study is the first to measure actual and perceived understanding of informed consent for parents who gave permission for their children to participate in a biobanking study. More than half of the parents were uncertain or responded incorrectly to the main questions of the study, including those regarding the use and storage of samples and the handling of results from the study. This is consistent with prior studies of adult biobanking participants. Ormond et al. 13 demonstrated that nearly half of the subjects enrolled in a biobanking study were unaware that their DNA would be stored at all, a finding that this study confirmed. It is possible that participants may not understand the connection between the samples they provide (blood or saliva) and the storage of DNA. It is also possible that participants were unable to recall the procedures that they learned during the informed consent process, even though time since consent for the LVOT study was not associated with knowledge. Nevertheless, the core concept of biobanking consent is DNA storage and to have so few parents understand that concept is cause for significant concern.
In this study, questions related to research procedures, the return of research results, and the use of leftover samples were more likely to be answered correctly by parents who indicated that both the mother and the father were involved with medical decision making. Dual-parent responsibility for medical decision making may be associated with an increased understanding of study procedures due to the added support of having both the parents involved in the consent process. This, in turn, could allow the parents to follow more closely during the consent procedure, ask more questions of research staff, and share information with each other after the informed consent procedure. Similarly, participants who were married were more likely to correctly answer questions about the study's purpose. Although this study does not examine differences in one-versus two-parent households, there is evidence in the diabetes literature that family and parenting stress is higher among single parents. 27, 28 Higher stress is a potential impediment to parents' ability to learn illness management skills for their children. 27 Of interest, the two questions regarding the indefinite storage of DNA were less likely to be answered correctly by parents in households where both the mother and the father participated in decision making. We hypothesize that participants related the questions about indefinite storage of samples (A9 and A12) to the question regarding the use of leftover samples by other researchers (A4) and responded similarly to these items. This emphasizes the need for clear consent form language, verbal explanation, and knowledge assessment when administering consent for biobanking so that potential participants understand the difference between indefinite storage and the use of their samples in future research. Brisson et al. 6 recommend using a separate document to explain procedures and obtain consent for the biobanking part of a study to clarify the possible uses of stored samples and provide subjects with an opportunity to decline.
Given that the parents in this study had given consent for their children to participate, it is not surprising that they deemed the study to be relatively risk free. More than 80% agreed that there were no risks of harm to themselves or their children while participating in the study even though there was a blood-draw involved, and most were unsure of who would pay for injuries. This is consistent with previous studies that show that consenting adults and parents consenting Original research article for their children minimize the risks of research participation. 29, 30 Our study also noted that these questions were frequently incorrectly answered even though the parents felt that they had a good understanding. We speculate that the required informed consent template originally created for interventional studies regarding risks, harms, and payment for injuries does not transfer well to biobanking studies, resulting in confusion. Study participants who reported income in the highest two categories were less likely to respond correctly to the item about payment for injuries sustained because of the study as compared with participants in the lowest category of income (<$35,000). We can only speculate that parents with lower incomes may be more concerned with paying for additional medical care because their children are uninsured or underinsured. Not surprisingly, shorter length of enrollment in the study was positively associated with answering this question correctly. More recent exposure to specific study details such as payment for injury may increase the ability of study participants to recall this information.
Parents in this study overestimated their understanding. We found discrepancies in the items that were answered correctly on the objective subscale versus what parents thought they understood on the subjective subscale. For example, there was only 33.7% concordance for questions A4 and B5 relating to the indefinite storage of blood/saliva or tissue samples. The Marshfield and Nugene studies demonstrated discrepancies between objective and subjective scores on the QuIC assessment. 13, 14 Although the questions in this study are slightly different from those of the previously mentioned studies, it is apparent from these combined results that biobanking participants appear to think that they understand more than they do. Future research should include assessments of actual and perceived understanding immediately following consent to confirm these results.
When the original LVOT study was conceived, it was not routine to return genetic results to individuals or their families. The advent of massively parallel sequencing and the ability to identify many genetic changes has recently changed the landscape of reporting research results, particularly for "incidental findings. " Multiple studies have shown that research participants want to receive results from the genetic research studies in which they participate, including results on children. 31 Our findings give some support for this. Even though the consent form stated that results would not be returned, the majority of respondents were expecting return of results or were not certain if results would be returned.
It is important to note the limitations of this study. The participants (parents of children in the LVOT study) were largely white, more educated, and more affluent than most families of children treated for other illnesses; therefore, these finding may not be applicable to families enrolling in biobanks for other childhood diseases. It is also important to note that our sample size was likely to demonstrate statistical significance only for medium-to-large differences in understanding; however, small differences are likely less clinically relevant.
In conclusion, our study adds to the wealth of research demonstrating that informed consent understanding is inadequate in a variety of populations. This study also adds a concerning dimension that many parents did not understand that DNA would be stored in a biobanking study. Interventions to improve understanding, including visual aids and video consenting, provide promising results, but no recent clinical trials demonstrating effectiveness for biobanking consent have been published, and there is currently no push to adopt these techniques widely. [32] [33] [34] [35] [36] [37] [38] [39] To provide individuals and families with adequate knowledge to participate in genetic research, informed consent delivery must improve as the demand for genomic data increases. The focus of researchers should now shift to how to improve the informed consent process through alternative methods of consent delivery.
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